Jaunākās ziņas un raksti par ģenētiskajiem testiem
Hair Health
May 21, 2026
A recent study has discovered micro-nano-plastics in artery-clogging plaque found in the neck arteries of individuals. This finding suggests a potential link between plastic pollution and cardiovascular disease.
Hair Health
May 21, 2026
Scientists have made a breakthrough in enzyme engineering that could lead to novel therapies for Parkinson's disease, various types of cancer, and other protein-based disorders. This innovative approach involves designing enzymes to specifically target and modify problematic proteins.
Hair Health
May 21, 2026
Salk Institute. "Estrogen-related receptors could be key to treating metabolic and muscular disorders." ScienceDaily. ScienceDaily, 13 May 2025. <www.sciencedaily.com/releases/2025/05/250512165549....
Hair Health
May 21, 2026
Researchers have conducted experiments to assess the efficacy of a new anti-aging cream. Preliminary results indicate that this topical treatment may possess significant anti-aging properties.
Hair Health
May 21, 2026
Scripps Research Institute. "Enzyme engineering opens door to novel therapies for Parkinson's, cancers and other hard-to-target protein diseases." ScienceDaily. ScienceDaily, 27 March 2025. <www.sc...
Hair Health
May 21, 2026
Researchers have identified a potential link between estrogen-related receptors and the treatment of metabolic and muscular disorders. Further study may reveal the therapeutic applications of these receptors.
Hair Health
May 21, 2026
Researchers at the University of California - Santa Cruz have developed an AI-powered smart bandage that accelerates wound healing by approximately 25%. This innovative technology utilizes artificial intelligence to monitor and respond to a patient's wound recovery.
Hair Health
May 21, 2026
KeAi Communications Co., Ltd.. "Scientists test an anti-aging cream that actually works." ScienceDaily. ScienceDaily, 15 September 2025. <www.sciencedaily.com/releases/2025/09/250914205851.htm>.
Hair Health
May 21, 2026
Researchers have developed a gene-based blood test that may help identify early signs of melanoma recurrence. This innovative tool has the potential to improve cancer treatment outcomes by detecting potential issues before they become severe.
